{
  "id": 2336474,
  "title": "Brii Biosciences advances HBV study data alongside half year financial results",
  "url": "https://urgent.news/2026/08/21/brii-biosciences-advances-hbv-study-data-alongside-half-year",
  "topic": "business",
  "section": "Business",
  "published": "2026-08-21T07:42:55.000Z",
  "source": {
    "name": "Vietnam Investment Review",
    "slug": "vietnam-investment-review",
    "url": "https://vir.com.vn/brii-biosciences-advances-hbv-study-data-alongside-half-year-financial-results-159187.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Biotechnology company Brii Biosciences released Phase 2b clinical data for its hepatitis B treatment strategy on 21 August 2026 alongside half year financial reporting",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}